The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Midazolam Rowa 10 mg oromucosal solution

Rowa Pharmaceuticals LimitedPA0074/099/004

Main Information

Trade NameMidazolam Rowa 10 mg oromucosal solution
Active SubstancesMidazolam
Dosage FormOromucosal solution
Licence HolderRowa Pharmaceuticals Limited
Licence NumberPA0074/099/004

Group Information

ATC CodeN05CD08 midazolam


License statusAuthorised
Licence Issued29/01/2021
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceThis product contains a substance listed in schedule 4, part 1 to the Misuse of Drugs Regulations 2017.
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back